SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology & Drugs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: 2MAR$ who wrote (217)1/29/2004 5:36:01 PM
From: 2MAR$  Read Replies (1) of 232
 
*** AFFX ($25~$31) posts sharply higher profit
Wednesday January 28, 4:31 pm ET

(Adds details throughout, 2004 outlook)
NEW YORK, Jan 28 (Reuters) - Affymetrix Inc. (NasdaqNM:AFFX - News), a maker of chips used for genetic research, said on Wednesday fourth-quarter profit rose sharply on higher sales of instruments to new customers and upgrades of older systems.

ADVERTISEMENT


The Santa Clara, California-based company reported net profit of $16 million, or 26 cents per share, compared with $2.9 million, or 5 cents a share, in the same period a year earlier.

Analysts on average expected earnings of 24 cents a share, according to Reuters Research, a unit of Reuters Group Plc.

Affymetrix said it expects revenue of $77 million in the first quarter of 2004, with full year total revenue of $345 million to $350 million.

Revenue for the fourth quarter rose to $89.2 million from $78.3 million a year ago.

Total costs for the quarter rose slightly to $74.2 million from $73.6 million a year ago. But research and development spending was down to $16.9 million from $18.8 million in the fourth quarter of 2002.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext